Your session is about to expire
← Back to Search
Electrodesiccation and Curettage vs Excision for Skin Surgery
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two methods for treating low-risk skin lesions on the body: scraping off the lesion with electric current versus cutting it out and stitching the wound. The study aims to see which method results in a better-looking scar and how it affects patients' quality of life. Electrosurgery is a well-established method for treating skin lesions, offering advantages such as rapid treatment and cosmetically acceptable results.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Scar Assessment
Secondary study objectives
Complications
Quality of Life Measures (DLQI)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: ExcisionExperimental Treatment1 Intervention
The excision arm will undergo standard excision with repair by complex linear closure.
Group II: ED&CExperimental Treatment1 Intervention
The ED\&C arm will receive the standard ED\&C care.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,755,629 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Women who are currently pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: ED&C
- Group 2: Excision
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger